These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 26648305)
1. [Transfected miR-1908 inhibits renal fibrosis via targeting transforming growth factor beta 1]. Xie F; Li X; Wei C; Gou L; Dang Y; Shan Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1682-5, 1689. PubMed ID: 26648305 [TBL] [Abstract][Full Text] [Related]
2. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway. Li R; Chung AC; Dong Y; Yang W; Zhong X; Lan HY Kidney Int; 2013 Dec; 84(6):1129-44. PubMed ID: 23868013 [TBL] [Abstract][Full Text] [Related]
3. Expression of miR-207 in renal tissue of renal fibrosis rats and its correlation analysis with protein expression of TGF-β1 and Smad3. Tian F; Zhang ZY; Sun J; Han YC Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):787-794. PubMed ID: 33577033 [TBL] [Abstract][Full Text] [Related]
4. miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway. Liu L; Pang X; Shang W; Feng G; Wang Z; Wang J Ren Fail; 2020 Nov; 42(1):513-522. PubMed ID: 32441195 [No Abstract] [Full Text] [Related]
5. Mechanistic study on lncRNA XIST/miR-124-3p/ITGB1 axis in renal fibrosis in obstructive nephropathy. Zhang C; Wang K; Chen X; Li Y Exp Cell Res; 2024 Sep; 442(1):114194. PubMed ID: 39127440 [TBL] [Abstract][Full Text] [Related]
6. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN. Ai K; Zhu X; Kang Y; Li H; Zhang L Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508 [TBL] [Abstract][Full Text] [Related]
7. Role of miR-24, Furin, and Transforming Growth Factor-β1 Signal Pathway in Fibrosis After Cardiac Infarction. Chen Z; Lu S; Xu M; Liu P; Ren R; Ma W Med Sci Monit; 2017 Jan; 23():65-70. PubMed ID: 28055991 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of elF3a inhibits collagen synthesis in renal fibroblasts via Inhibition of transforming growth factor-β1/Smad signaling pathway. Zhang YF; Wang Q; Luo J; Yang S; Wang JL; Li HY Int J Clin Exp Pathol; 2015; 8(8):8983-9. PubMed ID: 26464640 [TBL] [Abstract][Full Text] [Related]
9. MiR-1908 improves cardiac fibrosis after myocardial infarction by targeting TGF-β1. Chen Y; Li T; Gao Q; Wang LY; Cui LQ Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2061-2069. PubMed ID: 29687863 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-98 inhibits TGF-β1-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1. Cheng R; Dang R; Zhou Y; Ding M; Hua H Hum Cell; 2017 Jul; 30(3):192-200. PubMed ID: 28251559 [TBL] [Abstract][Full Text] [Related]
11. The long noncoding RNA myocardial infarction-associated transcript modulates the epithelial-mesenchymal transition in renal interstitial fibrosis. Wang Z; Zhang B; Chen Z; He Y; Ru F; Liu P; Chen X Life Sci; 2020 Jan; 241():117187. PubMed ID: 31863776 [TBL] [Abstract][Full Text] [Related]
12. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-499-5p inhibits transforming growth factor-β1-induced Smad2 signaling pathway and suppresses fibroblast proliferation and collagen synthesis in rat by targeting TGFβ-R1. Zhao Q; Yang W; Li X; Yuan H; Guo J; Wang Y; Shan Z Mol Biol Rep; 2023 Dec; 50(12):9757-9767. PubMed ID: 37676431 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα. Lyu H; Li X; Wu Q; Hao L J Pharmacol Sci; 2019 Sep; 141(1):70-78. PubMed ID: 31611175 [TBL] [Abstract][Full Text] [Related]
15. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517 [TBL] [Abstract][Full Text] [Related]
16. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation. Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933 [TBL] [Abstract][Full Text] [Related]
17. Gypenosides suppress fibrosis of the renal NRK-49F cells by targeting miR-378a-5p through the PI3K/AKT signaling pathway. Zhang L; Wang X; He S; Zhang F; Li Y J Ethnopharmacol; 2023 Jul; 311():116466. PubMed ID: 37031821 [TBL] [Abstract][Full Text] [Related]
18. Silenced miR-21 inhibits renal interstitial fibrosis via targeting ERK1/2 signaling pathway in mice. Tang CR; Luo SG; Lin X; Wang J; Liu Y Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):110-116. PubMed ID: 31389582 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 and Smad4 signaling pathway down-regulates renal extracellular matrix degradation in diabetic rats. Yang Q; Xie RJ; Yang T; Fang L; Han B; Zhang GZ; Cheng ML Chin Med Sci J; 2007 Dec; 22(4):243-9. PubMed ID: 18246672 [TBL] [Abstract][Full Text] [Related]